Barinthus Biotherapeutics (BRNS) Receivables - Net (2020 - 2023)
Barinthus Biotherapeutics' (BRNS) quarterly Receivables - Net came in at $172000.0 in Q1 2023, down 99.05% YoY from $18.0 million in Q1 2022, and down 96.89% on a QoQ basis from $5.5 million in Q4 2022.
Barinthus Biotherapeutics (BRNS) Receivables - Net (2020 - 2023) Analysis & Trends
Barinthus Biotherapeutics (BRNS) has 4 years of Receivables - Net data on file, last reported at $172000.0 in Q1 2023.
- Quarterly Receivables - Net fell 99.05% year-over-year to $172000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $172000.0 (down 99.05% YoY) and the FY2022 annual result came in at $5.5 million, up 27520.0% from the prior year.
- Receivables - Net retreated to $172000.0 in Q1 2023, from $5.5 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $18.0 million in Q1 2022 to a low of $20000.0 in Q4 2021.
- A 4-year average of $2.7 million and a median of $172000.0 in 2023 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2022 — Receivables - Net surged 27520.0% — and 2023, when it plunged 99.05%.
- Tracing BRNS's Receivables - Net over 4 years: stood at $518000.0 in 2020, then sank by 96.14% to $20000.0 in 2021, then surged by 27520.0% to $5.5 million in 2022, then tumbled by 96.89% to $172000.0 in 2023.
- The last three Receivables - Net figures came in at $172000.0 (Q1 2023), $5.5 million (Q4 2022), and $26000.0 (Q3 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Barinthus Biotherapeutics | 25.01 Mn | 25.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 172,000.00 |
| Mar 31, 2023 | 172,000.00 |
| Dec 31, 2022 | 5.52 Mn |
| Dec 31, 2022 | 5.52 Mn |
| Sep 30, 2022 | 26,000.00 |
| Sep 30, 2022 | 26,000.00 |
| Mar 31, 2022 | 18.01 Mn |
| Mar 31, 2022 | 18.01 Mn |
| Dec 31, 2021 | 20,000.00 |
| Dec 31, 2021 | 20,000.00 |
| Sep 30, 2021 | 42,000.00 |
| Sep 30, 2021 | 42,000.00 |
| Jun 30, 2021 | 37,000.00 |
| Jun 30, 2021 | 37,000.00 |
| Mar 31, 2021 | 312,000.00 |
| Mar 31, 2021 | 312,000.00 |
| Dec 31, 2020 | 518,000.00 |
| Dec 31, 2020 | 518,000.00 |